Hozefa Bandukwala is a Vice President, Science Partner at ĢƵAPP, where he explores ideas and founds new companies. One of his key accomplishments is co-founding Prologue Medicines, where he is the founding Chief Scientific Officer. In this role, he leads efforts to create transformative medicines by discovering and evaluating viral proteins and their unique features.
Hozefa’s passion for science began during his undergraduate studies in India when he came across an article in Scientific American about missile-like drug delivery systems — now known as antibody drug conjugates (ADCs). The ingenuity of leveraging the immune system for therapeutic purposes fascinated him. Until then, he had considered a medical career, but this moment shifted his path toward scientific pioneering.